The impact of exogenous l-arginine on cardiohaemodynamics and heart rhythm variability in patients with coronary heart disease after community-acquired pneumonia

Authors

DOI:

https://doi.org/10.15587/2519-4798.2017.97083

Keywords:

coronary heart disease, community-acquired pneumonia, cardiohemodynamics, heart rhythm variability, treatment, L-arginine

Abstract

Aim of the work: to study the influence of exogenous L-arginine on structural-functional indices of heart, intensity degree of myocardium coronary changes and heart rhythm variability in patients with coronary heart disease after community-acquired pneumonia. 

Methods of research: the open prospective study included 60 patients with CHD, exertional angina, 2-3 f.c., who underwent community-acquired pneumonia of 3 clinical group (men – 34, women – 26, age median 72,50 (66,00; 75,00) years old). All patients underwent clinical examination, included clinical-laboratory methods of examination, two-dimensional echocardioscopy and impulse-wave dopplerography, daily monitoring of ECG by Holter at admission to hospital and in 3 months. After singing the informed consent, the patients were randomized in 2 groups. Main group included 30 persons, who received L-arginine in addition to basic CHD therapy, 30 patients of control group received only basic therapy.

Results of research: patients of main group at secondary examination in three month demonstrated a tendency to decrease of final-diastolic volume of LV, reliable increase of fraction of left ventricle emission by 4,44% (р<0,05), and decrease of mean pressure in pulmonary artery was more significant (8,33% vs 2,94%; р<0,05). The inclusion of L-arginine in the scheme of CHD treatment favored the reliable (р<0,05) decrease of tachycardia duration by 49,77%, number of ventricular extrasystoles by  63,2%, duration of ST segment depression by 56,52%, increase of general heart rhythm variability (rMSSD – by 70,00%, ТР – by 97,42%) and decrease of LF/HF index by 11,67% at the expanse of activity of parasympathetic component comparing with patients, who received only basic therapy.

Conclusions: the addition of L-arginin to the basic therapy in patients with IHD has the positive influence of cardiohemodinamics, favors the decrease of intensity degree of coronary changes and normalization of sympatho-parasympathetic balance of vegetative nervous system

Author Biographies

Natalia Mykhailovska, Zaporizhzhia State Medical University Mayakovskiy ave., 26, Zaporizhzhia, Ukraine, 69035

MD, Professor, Head of Department

Departement of General Practice – Family Medicine 

Tamila Kulynych, Zaporizhzhia State Medical University Mayakovskiy ave., 26, Zaporizhzhia, Ukraine, 69035

Assistant

Departement of General Practice – Family Medicine 

References

  1. Kovalenko, V., Kornatskiy, V. (2016). Problemy zdorov’ia i medychnoi dopomogy ta model pokrashchennia v suchasnykh umovakh [The problems of health and health care and it's improuvment model in modern conditions]. Kiyv, 260.
  2. Lynnyck, M., Nedospasova, O., Tarasenko, O., Bushura, I., Nikiforova, L. (2016). Porivnialni dani pro rozpovsiudgenist khvorob organiv dykhannia i medychnu dopomogu khvorym na khvoroby pulmonologichnogo ta alergologichnogo profiliu v Ukraini za 2009–2015 rr [Comparative data on the prevalence of respiratory diseases and medical care for patients with pulmonary and allergy profile diseases in Ukraine for 2009–2015 years]. Kyiv: Lira-K, 48.
  3. Corrales-Medina, V. F., Suh, K. N., Rose, G., Chirinos, J. A., Doucette, S., Cameron, D. W., Fergusson, D. A. (2011). Cardiac Complications in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies. PLoS Medicine, 8 (6), e1001048. doi: 10.1371/journal.pmed.1001048
  4. Corrales-Medina, V. F., Musher, D. M., Shachkina, S., Chirinos, J. A. (2013). Acute pneumonia and the cardiovascular system. The Lancet, 381 (9865), 496–505. doi: 10.1016/s0140-6736(12)61266-5
  5. Kurilets, L. O. (2010). Osoblyvosti tsentralnoi hemodynamiky ta funktsii zovnishnyogo dykhannia u khvorykh na negospitalnu pnevmoniu 3 ta 4 grupy iz suputnioyu IHS [The features of central hemodynamics and respiratory function in patients with community acquired pneumonia 3 and 4 groupe and concomitant coronary artery disease]. Zaporozhye medical journal, 12 (3), 21–23.
  6. Yildirim, B., Biteker, F. S., Basaran, O., Alatas, O. D., Acar, E., Sozen, H. et. al. (2015). Is there a potential role for echocardiography in adult patients with CAP? The American Journal of Emergency Medicine, 33 (11), 1672–1676. doi: 10.1016/j.ajem.2015.06.036
  7. Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use (1996). Circulation, 93 (5), 1043–1065. doi: 10.1161/01.cir.93.5.1043
  8. Mykhailovska, N. S., Kulynych, T. O., Grytsay, G. V. (2014). Klinichnyi perebig, neirohumoralni ta hemodynamichni zminy u khvorykh na stabilnu stenokardiu napruzhennia na tli negospitalnoi pnevmonii [Clinical course, neurohumoral and hemodynamic disorders in patients with stable angina pectoris on the bacground of community-acquired pneumonia]. Pathologia, 2 (31), 55–59.
  9. Ostrovskiy, M., Varunkiv, O. (2013). Vplyv patogenetychno-obgruntovanoi medykamentoznoi terapii negospitalnoi pnevmonii na tli ishemichnoi khvoroby sertsia v osib, infikovanyh Chlamydophila pneumonia, na endobronhialni factory nespetsyfichnoi resystentnosti ta lokalnu imunnu vidpovid [The impact of pathogenesis-based drug therapy on endobronchial factors for non-specific resistance and a local immune response in patients with community-acquired pneumonia and coronary heart disease, infected with Chlamydophila pneumonia]. Ukrainskyi pulmonologichnyi zhurnal, 3, 63–67.
  10. Regulatory and directives documents of the Ministry of Health of Ukraine. Avable at: http://mozdocs.kiev.ua/likiview.php?id=33730
  11. Alyavi, A., Kamilova, U., Tulyaganova, D., Kayumova, N., Rajabova, D., Toshev, B. (2016). GW27-e0520 Influence of Tivortin on hemodynamic parameters in patients with coronary heart disease. Journal of the American College of Cardiology, 68 (16), C84. doi: 10.1016/j.jacc.2016.07.317
  12. Bocch, E. A., De Moraes, A. V., Esteves-Filho, A., Bacal, F., Auler, J. O., Carmona, M. J. et. al. (2000). L-Arginine reduces heart rate and improves hemodynamics in severe congestive heart failure. Clinical Cardiology, 23 (3), 205–210. doi: 10.1002/clc.4960230314
  13. Orea-Tejeda, A., Orozco-Gutierrez, J. J., Castillo-Martinez, L., Keirns-Davies, C., Montano-Hernandez, P., Vazquez-Diaz, O. et. al. (2012). Vliyanie L-arginina I tsitrullina na funktsiu endotelia sosudov u patsientov s serdechnoi nedostatochnostiu s sokhranennoi fraktsiei levogo zheludochka serdtsa [The effect of L-arginine and citrulline to vascular endothelial function in patients with heart failure with preserved ejection fraction of the left ventricle]. Terapia, 5, 44–48.
  14. Nagaya, N., Uematsu, M., Oya, H., Sato, N., Sakamaki, F., Kyotani, S. (2001). Short-term Oral Administration of l- Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine, 163 (4), 887–891. doi: 10.1164/ajrccm.163.4.2007116
  15. Kraydashenko, O., Shalmina, M. (2012). Endoteliyoposredovanyi effect tivortina u bolnyh s ishemicheskoy bolezniu serdtsa pozhilogo i starcheskogo vozrasta [Anti-ischemic effect of Tivortin in elderly patients with coronary heart disease]. Visnyk problem biologii i meditsiny, 2 (2), 105–109.
  16. Lee, C.-W., Li, D., Channon, K. M., Paterson, D. J. (2009). l-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats. Journal of Molecular and Cellular Cardiology, 47 (1), 149–155. doi: 10.1016/j.yjmcc.2009.03.023
  17. Lutay, M., Bugaenko, V., Moiseenko, O. et. al. (2011). Znachennia L-argininu v likuvanni khvoryh iz sertsevo-sudynnoiu patologieiu [The role of L-arginine in patients with cardiovascular disorders]. Ukrainskiy kardiologicheskiy zhurnal, 4, 96–107.
  18. Konopleva, L. F., Andreev, E. V. (2010). L-arginin pri ishemicheskoi bolezni sedtsa: issledovania prodolzhaiutsia [L-arginine in patients with coronary heart disease: study continues]. Therpia, 10 (51), 64–68.
  19. Tousoulis, D., Boger, R. H., Antoniades, C., Siasos, G., Stefanadi, E., Stefanadis, C. (2007). Mechanisms of Disease: L-arginine in coronary atherosclerosis – a clinical perspective. Nature Clinical Practice Cardiovascular Medicine, 4 (5), 274–283. doi: 10.1038/ncpcardio0878
  20. Kulynych, T. O. (2017). Klinichna efectyvnist zastosuvannia eksogennogo L-argininu v likuvanni khvorykh na ishemichnu khvorobu serdtsia, yaki perenesly negospitalnu pnevmoniu [Clinical effectiveness of exogenous L-arginine in patients with coronary heart disease after community-acquired pneumonia]. Zaporozhye medical journal, 19 (1), 9–13.

Downloads

Published

2017-03-31

How to Cite

Mykhailovska, N., & Kulynych, T. (2017). The impact of exogenous l-arginine on cardiohaemodynamics and heart rhythm variability in patients with coronary heart disease after community-acquired pneumonia. ScienceRise: Medical Science, (3 (11), 27–34. https://doi.org/10.15587/2519-4798.2017.97083

Issue

No. 3 (11) (2017)

Section

Medical Science

License

Copyright (c) 2017 Natalia Mykhailovska, Tamila Kulynych

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.